Kiora Pharmaceuticals Inc (KPRX) insider trading

Every open-market stock purchase and sale by Kiora Pharmaceuticals Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: Carmine N. Stengone (Director), $4.6K, 2 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $2.76 on Sep 18, 2026.

Recent KPRX insider trades

DateInsiderTradeValue
Sep 17, 2026Keith J. Lane (Insider)Bought (not open market)—
Jun 10, 2026Erin Parsons (Director)Bought (not open market)—
Jun 10, 2026Carmine N. Stengone (Director)Bought (not open market)—
Jun 10, 2026Aron Shapiro (Director)Bought (not open market)—
Jun 10, 2026David Hollander (Director)Bought (not open market)—
Jun 10, 2026Praveen Tyle (Director)Bought (not open market)—
Jun 10, 2026Lisa Walters-Hoffert (Director)Bought (not open market)—
Apr 1, 2026Brian M. Strem (CEO)Sold (not open market)$3.7K
Apr 1, 2026Eric Joseph Daniels (C-suite exec)Sold (not open market)$1.8K
Apr 1, 2026Melissa Tosca (CFO)Sold (not open market)$1.8K
Mar 6, 2026Brian M. Strem (CEO)Bought (not open market)—
Mar 6, 2026Brian M. Strem (CEO)Bought (not open market)—
Mar 6, 2026Eric Joseph Daniels (C-suite exec)Bought (not open market)—
Mar 6, 2026Melissa Tosca (CFO)Bought (not open market)—
Mar 6, 2026Melissa Tosca (CFO)Bought (not open market)—
Mar 6, 2026Eric Joseph Daniels (C-suite exec)Bought (not open market)—
Mar 3, 2026Brian M. Strem (CEO)Sold (not open market)$481
Mar 3, 2026Eric Joseph Daniels (C-suite exec)Sold (not open market)$481

Who's trading KPRX

Get free alerts when an insider at Kiora Pharmaceuticals Inc files a new trade →